Nottinghamshire Healthcare NHS FT is a partner in this exciting new 4 year programme with European and Australian partners, funded by the EU. MindTech’s Tom Dening and Mike Craven are running the NHT end of the programme along with consultant clinical psychologist & neuropsychologist Dons Coleston and MindTech’s patient and public involvement team, all based at the Institute of Mental Health, University of Nottingham Jubilee Campus.

The MinD programme involves multiple exchange visits and technology design projects.

Press Release for more details:,-funded-by-the-eu.html

The partners involved in the MinD project are:

1) Universities - University of Wolverhampton, Universiteit Twente (NL), Technische Universitaet Dresden (DE), Université de Luxembourg , Queensland University of Technology

2) Dementia care & policy - Alzheimer Europe (LX), Nottinghamshire Healthcare NHS Foundation Trust, Alexianer St Hedwig Klinik Berlin (DE), Zorggroep Sint Marten (NL)

3) Design and ICT – Panton Design (NL), Picharchitects (ES), Eurecat (ES), INTRAS (ES)

During this four-year project, which will run until February 2020, the partners will work together to design and create a number of experiential prototypes to support people with dementia. These will cover designing to help with personal difficulties with social engagement, and designing the environment to help with social engagement.

The project will be carried out through a series of 15-day exchanges in the partner countries: the UK, Germany, the Netherlands, Luxemburg, Spain and Australia. Researchers will be hosted by one of the partners as they work on issues such as data collection, design development, implementation and testing of the designs. The first exchanges will take place in May 2016 and will be hosted by University of Wolverhampton and Nottinghamshire Healthcare NHS Foundation Trust.

For more information, please go to the MinD project website at

EU logo, acknowledgement and disclaimer.
eu logo

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 691001.

This document reflects only the author's view and the Research Executive Agency is not responsible for any use that may be made of the information it contains.